Biodexa Pharmaceuticals (BDRX) Cash & Equivalents (2013 - 2026)
Biodexa Pharmaceuticals (BDRX) reported Cash & Equivalents of $4.33 million for the quarter ended Jun 30, 2026, down 19.5% from $5.38 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Cash & Equivalents (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Biodexa Pharmaceuticals posted Cash & Equivalents of $11.25 million, up 427.4% from the prior year.
- Cash & Equivalents has a five-year compound annual growth rate of 3.0% (years ended Dec 2020 to Dec 2025).
- By year, Cash & Equivalents came in at $2.13 million in the year ended Dec 31, 2024 (-71.3%), $7.43 million in the year ended Dec 31, 2023 (+111.6%), $3.51 million in the year ended Dec 31, 2022 (-74.6%) and $13.84 million in the year ended Dec 31, 2021 (+42.8%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Cash & Equivalents since the quarter ended Dec 31, 2024.
- Year over year, Cash & Equivalents gained in 1 of the last four quarters, with growth averaging 80.9%.
- The high point for year-over-year Cash & Equivalents in five years was the quarter ended Dec 31, 2025 (growth of 429.9%); the low point was the quarter ended Dec 31, 2022 (a decline of 75.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Biodexa Pharmaceuticals | 41.69 Mn | 18.48 Mn | - | 4.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.33 Mn |
| Dec 31, 2025 | 11.35 Mn |
| Jun 30, 2025 | 5.38 Mn |
| Dec 31, 2024 | 2.14 Mn |
| Jun 30, 2024 | 6.38 Mn |
| Dec 31, 2023 | 7.41 Mn |
| Jun 30, 2023 | 6.54 Mn |
| Dec 31, 2022 | 3.33 Mn |
| Jun 30, 2022 | 8.09 Mn |
| Dec 31, 2021 | 13.56 Mn |
| Jun 30, 2021 | 5.88 Mn |
| Dec 31, 2020 | 9.96 Mn |
| Jun 30, 2020 | 5.37 Mn |
| Dec 31, 2019 | 14.05 Mn |
| Jun 30, 2019 | 11.55 Mn |
| Dec 31, 2018 | 3.01 Mn |
| Jun 30, 2018 | 5.92 Mn |
| Dec 31, 2017 | 17.53 Mn |
| Jun 30, 2017 | 7.90 Mn |
| Dec 31, 2016 | 21.89 Mn |
API Access
Biodexa Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();